Tirzepatide Dosage Calculator
Calculate injection volumes for tirzepatide. Pre-filled for a 10mg vial with 2ml BAC water (5,000 mcg/ml).
Dose Reference Table
Pre-calculated for a 10mg vial + 2ml BAC water = 5,000 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.
| Dose | Inject Volume (ml) | Syringe Units |
|---|---|---|
| 1250mcg (1.25mg) | 0.250 ml | 25 units |
| 2500mcg (2.5mg) | 0.500 ml | 50 units |
| 5000mcg (5mg) | 1.000 ml | 100 units |
| 7500mcg (7.5mg) | 1.500 ml | 150 units |
| 10000mcg (10mg) | 2.000 ml | 200 units |
About Tirzepatide
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It was developed and is FDA-approved under the brand name Mounjaro for type 2 diabetes and Zepbound for obesity. In research settings, it has attracted interest for its superior weight reduction efficacy compared to GLP-1 monotherapy agents.
Research-grade tirzepatide is commonly supplied in 5mg, 10mg, and 15mg vials. The most practical reconstitution for a 10mg vial is 2ml of bacteriostatic water, yielding 5,000 mcg/ml. At this concentration, doses are expressed in milligrams for convenience: 2.5mg = 0.5ml = 50 units.
Tirzepatide has a half-life of approximately 5 days, supporting once-weekly subcutaneous administration. The recommended escalation schedule typically starts at 2.5mg/week and increases by 2.5mg every 4 weeks up to a maximum of 15mg/week based on tolerability.